Collect. Czech. Chem. Commun. 2010, 75, 703-719
https://doi.org/10.1135/cccc2010023
Published online 2010-06-30 19:27:02

Identification of human enzymes oxidizing a human metabolite of carcinogenic 2-nitroanisole, 2-nitrophenol. Evidence for its oxidative detoxification by human cytochromes P450

Martina Svobodováa, Markéta Martínkováa, Eva Freib and Marie Stiborováa,*

a Department of Biochemistry, Faculty of Natural Sciences, Charles University in Prague, Albertov 2030, 128 43 Prague 2, Czech Republic
b German Cancer Research Center, Im Neuenheimar Feld 280, 69120 Heidelberg, Germany

References

1. Garner R. C., Martin C. N., Clayson D. B. in: Chemical Carcinogens (C. Searle, Ed.), 2nd ed., p. 175. American Chemical Society, Washington, DC 1985.
2. International Agency for Research in Cancer (IARC): IARC Monographs on the Evaluation of Carcinogenic Risk to Humans. Vol. 46, IARC, Lyon 1989.
3. Purohit V., Basu A. K.: Chem. Res. Toxicol. 2000, 13, 673. <https://doi.org/10.1021/tx000002x>
4. Mikšanová M., Šulc M., Rýdlová H., Schmeiser H. H., Frei E., Stiborová M.: Chem. Res. Toxicol. 2004, 17, 663. <https://doi.org/10.1021/tx0499721>
5. Rýdlová H., Mikšanová M., Ryšlavá H., Stiborová M: Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub. 2005, 149, 441. <https://doi.org/10.5507/bp.2005.077>
6. Dračínská H., Mikšanová M., Svobodová M, Smrček S., Frei E., Schmeiser H. H., Stiborová M.: Neuroendocrinol. Lett. 2006, 27 (Suppl. 2), 9.
7. Svobodová M., Dračínská H., Martínková M., Hudeček J., Hodek P., Frei E., Stiborová M.: Interdiscip. Toxicol. 2008, 1, 182. <https://doi.org/10.2478/v10102-010-0035-x>
8. Miller M. J., Sipes I. G., Perry D. F., Carter D. E.: Drug Metab. Dispos. 1985, 13, 527.
9. NTP: Bioassay of o-Anisidine Hydrochloride for Possible Carcinogenicity, NTP Technical Report 89. National Institute of Health, U.S. Department of Health and Human Services, Bethesda (MD) 1978.
10. NTP: Toxicology and Carcinogenesis. Studies of 2-Nitroanisole, NTP Technical Report 89. National Institute of Health, U.S. Department of Health and Human Services, Bethesda (MD) 1993.
11. Hengstler J. G., Fuchs J., Bolm-Audorff U., Meyer S., Oesch F.: Scand J. Work Environ. Health 1995, 21, 36. <https://doi.org/10.5271/sjweh.6>
12. Traupe H., Menge G., Kandt I., Karmaus W.: Dermatology 1997, 195, 112. <https://doi.org/10.1159/000245711>
13. Mikšanová M., Novák P., Frei E., Stiborová M.: Collect. Czech. Chem. Commun. 2004, 69, 589. <https://doi.org/10.1135/cccc20040589>
14. Stiborová M., Mikšanová M., Smrček S., Bieler C. A., Breuer A., Schmeiser H. H., Frei E.: Carcinogenesis 2004, 25, 833. <https://doi.org/10.1093/carcin/bgh061>
15. Stiborová M., Schmeiser H. H., Frei E.: Collect. Czech. Chem. Commun. 1998, 63, 857. <https://doi.org/10.1135/cccc19980857>
16. Svobodová M., Martínková M., Dračínská H., Frei E., Stiborová M.: Neuroendocrinol. Lett. 2009, 30 (Suppl. 1), 46.
17. Stiborová M., Frei E., Breuer A., Wiessler M., Schmeiser H. H.: Mutat. Res. 2001, 493, 149. <https://doi.org/10.1016/S1383-5718(01)00171-1>
18. Frei E., Bieler C. A., Arlt V. M., Wiessler M., Stiborová M.: Biochem. Pharmacol. 2002, 64, 289. <https://doi.org/10.1016/S0006-2952(02)01072-9>
19. Arlt V. M., Hewer A., Sorg B. L., Schmeiser H. H., Phillips D. H., Stiborová M.: Chem. Res. Toxicol. 2004, 17, 1092. <https://doi.org/10.1021/tx049912v>
20. Stiborová M., Martínek V., Rýdlová H., Hodek P., Frei E.: Cancer Res. 2002, 62, 5678.
21. Arlt V. M., Stiborová M., Henderson C. J., Thiemann M., Frei E., Aimová D., Singhs R., da Costa G. G., Schmitz O. J., Farmer P. B., Wolf C. R., Phillips D. H.: Carcinogenesis 2008, 29, 656. <https://doi.org/10.1093/carcin/bgn002>
22. Stiborová M., Mikšanová M., Šulc M., Rýdlová H., Schmeiser H. H., Frei E.: Int. J. Cancer 2005, 116, 667. <https://doi.org/10.1002/ijc.21122>
23. Stiborová M., Arlt V. M., Henderson C. J., Wolf C. R., Kotrbová V., Moserová M., Hudeček J., Phillips D. H., Frei E.: Toxicol. Appl. Pharmacol. 2008, 226, 318. <https://doi.org/10.1016/j.taap.2007.09.017>
24. Wiechelman K. J., Braun R. D., Fitzpatrik J. D.: Anal. Biochem. 1988, 175, 231. <https://doi.org/10.1016/0003-2697(88)90383-1>
25. Omura T., Sato R.: J. Biol. Chem. 1964, 239, 2370.
26. Cleland W. W.: Methods Enzymol. 1983, 63, 103. <https://doi.org/10.1016/0076-6879(79)63008-2>
27. Rendic S., DiCarlo F. J.: Drug Metab. Rev. 1997, 29, 413. <https://doi.org/10.3109/03602539709037591>
28. Yamazoe Y., Zenser T. V., Miller D. W., Kadlubar F. F.: Carcinogenesis 1988, 9, 1635. <https://doi.org/10.1093/carcin/9.9.1635>
29. Gupta R. C., Reddy M. V., Randerath K.: Carcinogenesis 1982, 3, 1081. <https://doi.org/10.1093/carcin/3.9.1081>
30. Randerath K., Randerath E., Agrawal H. P., Gupta R. C., Schurdak M. E., Reddy M. V.: Environ. Health Perspect. 1985, 62, 57. <https://doi.org/10.2307/3430093>
31. Randerath E., Agrawal H. P., Weaver J. A., Bordelon C. B., Randerath K.: Carcinogenesis 1985, 6, 1117. <https://doi.org/10.1093/carcin/6.8.1117>
32. Reddy M. V., Randerath K.: Carcinogenesis 1986, 7, 1543. <https://doi.org/10.1093/carcin/7.9.1543>
33. Reddy M. V., Bleicher W. T., Blackburn G. R., Mackerer E. R.: Carcinogenesis 1990, 11, 1349. <https://doi.org/10.1093/carcin/11.8.1349>
34. Lewis D. F.: Curr. Med. Chem. 2003, 10, 1955. <https://doi.org/10.2174/0929867033456855>